Your browser is no longer supported. Please, upgrade your browser.
Settings
UTHR [NASD]
United Therapeutics Corporation
Index- P/E17.54 EPS (ttm)11.56 Insider Own0.20% Shs Outstand44.50M Perf Week6.11%
Market Cap8.92B Forward P/E14.29 EPS next Y14.19 Insider Trans-6.69% Shs Float43.66M Perf Month23.57%
Income514.80M PEG- EPS next Q2.93 Inst Own99.90% Short Float5.35% Perf Quarter23.49%
Sales1.48B P/S6.01 EPS this Y583.80% Inst Trans1.09% Short Ratio6.07 Perf Half Y94.51%
Book/sh76.30 P/B2.66 EPS next Y11.11% ROA11.90% Target Price201.67 Perf Year104.81%
Cash/sh41.73 P/C4.86 EPS next 5Y-10.88% ROE16.20% 52W Range94.26 - 204.77 Perf YTD33.59%
Dividend- P/FCF12.80 EPS past 5Y-1.90% ROI10.90% 52W High-0.97% Beta0.48
Dividend %- Quick Ratio6.40 Sales past 5Y0.20% Gross Margin92.70% 52W Low115.13% ATR6.86
Employees950 Current Ratio6.70 Sales Q/Q23.70% Oper. Margin39.30% RSI (14)72.38 Volatility3.28% 3.50%
OptionableYes Debt/Eq0.24 EPS Q/Q82.00% Profit Margin34.70% Rel Volume0.96 Prev Close199.30
ShortableYes LT Debt/Eq0.24 EarningsFeb 24 BMO Payout0.00% Avg Volume384.55K Price202.78
Recom2.10 SMA2013.06% SMA5017.84% SMA20047.36% Volume368,598 Change1.75%
Feb-01-21Upgrade H.C. Wainwright Neutral → Buy $125 → $195
Sep-14-20Resumed JP Morgan Overweight $142
Jun-25-20Reiterated H.C. Wainwright Neutral $85 → $125
Mar-10-20Upgrade Jefferies Hold → Buy $123
Feb-27-20Upgrade Cowen Market Perform → Outperform $119 → $145
Jan-31-20Upgrade JP Morgan Neutral → Overweight $120
Dec-03-19Initiated BofA/Merrill Underperform
Aug-01-19Upgrade Ladenburg Thalmann Neutral → Buy $103 → $106
Aug-01-19Upgrade Jefferies Underperform → Hold $90
Jul-01-19Upgrade Credit Suisse Neutral → Outperform $98 → $101
May-17-19Upgrade UBS Sell → Neutral $115 → $94
May-09-19Upgrade Credit Suisse Underperform → Neutral $98
Oct-12-18Upgrade Standpoint Research Hold → Buy
Aug-08-18Downgrade Credit Suisse Neutral → Underperform
Apr-03-18Upgrade Credit Suisse Underperform → Neutral
Feb-22-18Reiterated Barclays Underweight $115 → $105
Jan-18-18Resumed Credit Suisse Underperform $118
Dec-27-17Reiterated Wedbush Outperform $213 → $232
Apr-27-17Reiterated Wedbush Outperform $229 → $213
Mar-30-17Initiated UBS Sell $112
Apr-06-21 03:16PM  
Apr-05-21 08:13AM  
Apr-02-21 07:07AM  
06:50AM  
Apr-01-21 08:25AM  
08:24AM  
06:00AM  
Mar-26-21 11:31AM  
Mar-24-21 06:00AM  
Mar-09-21 06:00AM  
Mar-03-21 11:05AM  
07:38AM  
Feb-27-21 03:05AM  
Feb-25-21 02:30PM  
Feb-24-21 04:30PM  
02:30PM  
07:15AM  
07:07AM  
Feb-18-21 05:20AM  
Feb-17-21 06:00AM  
Feb-10-21 06:00AM  
Jan-28-21 04:51PM  
06:00AM  
Jan-27-21 04:13PM  
08:30AM  
Jan-21-21 11:00PM  
Jan-20-21 10:30AM  
Jan-13-21 05:01PM  
Jan-07-21 09:28AM  
Jan-04-21 06:00AM  
05:04AM  
Dec-28-20 09:00AM  
06:00AM  
Dec-20-20 07:03PM  
Dec-15-20 04:13PM  
Dec-09-20 06:00AM  
Nov-27-20 11:31AM  
Nov-26-20 09:14AM  
Nov-24-20 06:00AM  
Nov-10-20 06:00AM  
Nov-05-20 01:20PM  
Nov-02-20 05:55AM  
Oct-28-20 02:31PM  
12:13PM  
07:30AM  
07:22AM  
07:00AM  
06:00AM  
Oct-27-20 11:59AM  
09:12AM  
Oct-22-20 06:00AM  
Oct-21-20 06:00AM  
Oct-15-20 06:00AM  
Sep-21-20 07:00AM  
Sep-17-20 01:01PM  
Sep-16-20 06:00AM  
Sep-11-20 06:00AM  
Sep-09-20 10:43AM  
Aug-28-20 11:31AM  
Aug-18-20 11:13AM  
Aug-17-20 07:31AM  
06:00AM  
Aug-05-20 06:00AM  
Jul-30-20 07:32PM  
11:41AM  
Jul-29-20 08:02PM  
08:47AM  
07:30AM  
07:23AM  
Jul-23-20 06:00AM  
Jul-22-20 12:32PM  
06:00AM  
Jul-15-20 01:15PM  
Jul-13-20 04:18PM  
Jul-07-20 11:14AM  
Jul-06-20 10:35AM  
Jun-30-20 05:18PM  
Jun-17-20 06:00AM  
Jun-16-20 08:37PM  
Jun-09-20 02:56PM  
Jun-08-20 12:29PM  
Jun-05-20 11:06AM  
06:00AM  
May-29-20 11:31AM  
May-28-20 11:34AM  
May-26-20 06:00AM  
May-14-20 01:46PM  
May-06-20 06:00AM  
May-04-20 02:29PM  
May-01-20 12:00PM  
Apr-30-20 08:00AM  
Apr-29-20 06:31PM  
07:30AM  
06:00AM  
Apr-23-20 06:00AM  
Apr-09-20 11:00AM  
Apr-01-20 05:50PM  
Mar-27-20 02:53PM  
11:30AM  
Mar-16-20 11:30AM  
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhance the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing OreniPro, RemoPro, Tyvaso DPI, Trevyent, Ralinepag, and Aurora-GT to treat PAH; Unexisome to treat bronchopulmonary dysplasia; and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. It has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder and Dreamboat devices; and Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DWEK RAYMONDDirectorApr 07Option Exercise54.772,000109,5402,000Apr 08 05:26 PM
Olian Judy D.DirectorApr 01Option Exercise76.364,207321,2479,997Apr 02 09:33 AM
MAHON PAUL AEVP & General CounselApr 01Option Exercise94.966,000569,76042,369Apr 02 09:35 AM
Olian Judy D.DirectorApr 01Sale184.964,207778,1275,790Apr 02 09:33 AM
KURZWEIL RAYDirectorMar 26Option Exercise54.773,750205,38811,290Mar 29 04:31 PM
MAHON PAUL AEVP & General CounselMar 18Option Exercise94.966,000569,76042,369Mar 19 04:32 PM
Olian Judy D.DirectorMar 17Option Exercise76.362,103160,5857,893Mar 19 04:32 PM
Olian Judy D.DirectorMar 17Sale170.002,103357,5105,790Mar 19 04:32 PM
Thompson Tommy GDirectorMar 10Option Exercise54.7712,350676,41017,190Mar 11 04:35 PM
MAHON PAUL AEVP & General CounselMar 04Option Exercise94.966,000569,76042,369Mar 05 05:26 PM
MAHON PAUL AEVP & General CounselFeb 18Option Exercise94.966,000569,76042,131Feb 19 04:33 PM
MAHON PAUL AEVP & General CounselFeb 04Option Exercise94.966,000569,76042,131Feb 05 04:31 PM
MAHON PAUL AEVP & General CounselJan 21Option Exercise94.966,000569,76042,131Jan 22 04:31 PM
CAUSEY CHRISTOPHERDirectorJan 15Option Exercise88.031,500132,0452,325Jan 19 04:39 PM
MAHON PAUL AEVP & General CounselJan 07Option Exercise94.966,000569,76042,131Jan 08 04:39 PM
CAUSEY CHRISTOPHERDirectorJan 07Option Exercise88.031,500132,0452,325Jan 08 04:38 PM
CAUSEY CHRISTOPHERDirectorJan 06Option Exercise88.031,500132,0452,325Jan 08 04:38 PM
Giltner RichardDirectorJan 06Option Exercise48.1110,000481,10018,350Jan 08 04:36 PM
Giltner RichardDirectorJan 05Option Exercise48.115,000240,55013,350Jan 06 04:35 PM
CAUSEY CHRISTOPHERDirectorJan 05Option Exercise88.031,500132,0452,325Jan 06 04:31 PM
CAUSEY CHRISTOPHERDirectorDec 31Option Exercise88.037,500660,2258,325Jan 04 04:30 PM
CAUSEY CHRISTOPHERDirectorDec 23Option Exercise88.031,500132,0452,325Dec 28 04:32 PM
MAHON PAUL AEVP & General CounselDec 17Option Exercise94.966,000569,76042,131Dec 18 04:58 PM
Giltner RichardDirectorDec 17Option Exercise54.775,000273,85013,350Dec 18 04:56 PM
PATUSKY CHRISTOPHERDirectorDec 08Option Exercise63.903,000191,7005,300Dec 09 04:31 PM
MAHON PAUL AEVP & General CounselDec 03Option Exercise94.966,000569,76042,131Dec 04 04:51 PM
DWEK RAYMONDDirectorNov 10Option Exercise48.112,00096,2202,000Nov 12 04:33 PM
MAHON PAUL AEVP & General CounselNov 05Option Exercise94.966,000569,76042,131Nov 06 04:31 PM
Giltner RichardDirectorNov 04Option Exercise54.775,000273,85013,350Nov 05 04:33 PM
DWEK RAYMONDDirectorNov 02Option Exercise54.775,000273,8505,000Nov 03 04:44 PM
BENKOWITZ MICHAELPresident and COONov 02Option Exercise63.4228,2001,788,42023,748Nov 03 04:43 PM
CAUSEY CHRISTOPHERDirectorOct 28Option Exercise63.902,000127,8002,825Oct 29 04:32 PM
CAUSEY CHRISTOPHERDirectorOct 22Option Exercise63.902,500159,7503,325Oct 23 04:32 PM
CAUSEY CHRISTOPHERDirectorOct 16Option Exercise63.902,250143,7752,325Oct 19 04:33 PM
PATUSKY CHRISTOPHERDirectorAug 05Option Exercise54.775,000273,8507,300Aug 06 06:13 PM
ROTHBLATT MARTINE AChairman & CEOJul 09Option Exercise63.224,834305,6054,974Jul 09 07:58 PM
ROTHBLATT MARTINE AChairman & CEOJul 09Sale117.044,834565,782140Jul 09 07:58 PM
ROTHBLATT MARTINE AChairman & CEOJul 08Option Exercise63.2210,000632,20010,140Jul 08 07:54 PM
ROTHBLATT MARTINE AChairman & CEOJul 08Sale117.9110,0001,179,051140Jul 08 07:54 PM
ROTHBLATT MARTINE AChairman & CEOJul 07Option Exercise63.2210,000632,20010,140Jul 08 07:54 PM
ROTHBLATT MARTINE AChairman & CEOJul 07Sale119.3110,0001,193,095140Jul 08 07:54 PM
ROTHBLATT MARTINE AChairman & CEOJul 06Option Exercise63.2210,000632,20010,140Jul 08 07:54 PM
ROTHBLATT MARTINE AChairman & CEOJul 06Sale119.6010,0001,196,030140Jul 08 07:54 PM
CAUSEY CHRISTOPHERDirectorJul 02Option Exercise63.9075047,9251,575Jul 06 08:04 AM
ROTHBLATT MARTINE AChairman & CEOJul 02Option Exercise63.2210,000632,20010,140Jul 02 04:58 PM
ROTHBLATT MARTINE AChairman & CEOJul 02Sale120.7310,0001,207,257140Jul 02 04:58 PM
ROTHBLATT MARTINE AChairman & CEOJul 01Option Exercise63.2210,000632,20010,140Jul 02 04:58 PM
ROTHBLATT MARTINE AChairman & CEOJul 01Sale121.3910,0001,213,877140Jul 02 04:58 PM
ROTHBLATT MARTINE AChairman & CEOJun 30Option Exercise63.2210,000632,20010,140Jul 01 07:14 PM
ROTHBLATT MARTINE AChairman & CEOJun 30Sale120.3610,0001,203,586140Jul 01 07:14 PM
ROTHBLATT MARTINE AChairman & CEOJun 29Option Exercise63.2210,000632,20010,140Jul 01 07:14 PM
ROTHBLATT MARTINE AChairman & CEOJun 29Sale120.0110,0001,200,103140Jul 01 07:14 PM
DWEK RAYMONDDirectorJun 29Sale116.814,600537,3230Jun 30 01:56 PM
PATUSKY CHRISTOPHERDirectorJun 26Option Exercise0.002,30002,300Jun 30 02:03 PM
SULLIVAN LOUIS WDirectorJun 26Option Exercise0.002,30009,420Jun 30 02:03 PM
Olian Judy D.DirectorJun 26Option Exercise0.002,30005,790Jun 30 02:02 PM
Mesa NildaDirectorJun 26Option Exercise0.002,30004,960Jun 30 01:59 PM
KURZWEIL RAYDirectorJun 26Option Exercise0.002,30007,540Jun 30 01:59 PM
Giltner RichardDirectorJun 26Option Exercise0.004,60008,350Jun 30 01:57 PM
DWEK RAYMONDDirectorJun 26Option Exercise0.004,60004,600Jun 30 01:56 PM
ROTHBLATT MARTINE AChairman & CEOJun 26Option Exercise63.2210,000632,20010,140Jun 26 05:39 PM
ROTHBLATT MARTINE AChairman & CEOJun 26Sale121.0010,0001,210,047140Jun 26 05:39 PM
ROTHBLATT MARTINE AChairman & CEOJun 25Option Exercise63.2210,000632,20010,140Jun 26 05:39 PM
ROTHBLATT MARTINE AChairman & CEOJun 25Sale125.0610,0001,250,607140Jun 26 05:39 PM
ROTHBLATT MARTINE AChairman & CEOJun 24Option Exercise63.2210,000632,20010,140Jun 24 05:34 PM
ROTHBLATT MARTINE AChairman & CEOJun 24Sale120.3410,0001,203,404140Jun 24 05:34 PM
ROTHBLATT MARTINE AChairman & CEOJun 23Option Exercise63.2210,000632,20010,140Jun 24 05:34 PM
ROTHBLATT MARTINE AChairman & CEOJun 23Sale120.4610,0001,204,650140Jun 24 05:34 PM
ROTHBLATT MARTINE AChairman & CEOJun 22Option Exercise63.2210,000632,20010,140Jun 24 05:34 PM
ROTHBLATT MARTINE AChairman & CEOJun 22Sale117.8110,0001,178,100140Jun 24 05:34 PM
ROTHBLATT MARTINE AChairman & CEOJun 19Option Exercise63.2210,000632,20010,140Jun 19 05:38 PM
ROTHBLATT MARTINE AChairman & CEOJun 19Sale116.7610,0001,167,568140Jun 19 05:38 PM
ROTHBLATT MARTINE AChairman & CEOJun 18Option Exercise63.2210,000632,20010,140Jun 19 05:38 PM
ROTHBLATT MARTINE AChairman & CEOJun 18Sale115.9510,0001,159,453140Jun 19 05:38 PM
ROTHBLATT MARTINE AChairman & CEOJun 17Option Exercise63.2210,000632,20010,140Jun 17 06:00 PM
ROTHBLATT MARTINE AChairman & CEOJun 17Sale117.8210,0001,178,173140Jun 17 06:00 PM
ROTHBLATT MARTINE AChairman & CEOJun 16Option Exercise63.2210,000632,20010,140Jun 17 06:00 PM
ROTHBLATT MARTINE AChairman & CEOJun 16Sale114.3110,0001,143,148140Jun 17 06:00 PM
ROTHBLATT MARTINE AChairman & CEOJun 15Option Exercise63.2210,000632,20010,140Jun 17 06:00 PM
ROTHBLATT MARTINE AChairman & CEOJun 15Sale113.8710,0001,138,662140Jun 17 06:00 PM
ROTHBLATT MARTINE AChairman & CEOJun 12Option Exercise63.2210,000632,20010,140Jun 12 05:02 PM
ROTHBLATT MARTINE AChairman & CEOJun 12Sale115.6910,0001,156,897140Jun 12 05:02 PM
ROTHBLATT MARTINE AChairman & CEOJun 11Option Exercise63.2210,000632,20010,140Jun 12 05:02 PM
ROTHBLATT MARTINE AChairman & CEOJun 11Sale118.0310,0001,180,302140Jun 12 05:02 PM
ROTHBLATT MARTINE AChairman & CEOJun 10Option Exercise63.2210,000632,20010,140Jun 10 04:49 PM
ROTHBLATT MARTINE AChairman & CEOJun 10Sale124.7810,0001,247,834140Jun 10 04:49 PM
ROTHBLATT MARTINE AChairman & CEOJun 09Option Exercise63.2210,000632,20010,140Jun 10 04:49 PM
ROTHBLATT MARTINE AChairman & CEOJun 09Sale125.6910,0001,256,950140Jun 10 04:49 PM
Thompson Tommy GDirectorJun 09Sale126.794,210533,8069,790Jun 10 04:50 PM
ROTHBLATT MARTINE AChairman & CEOJun 08Option Exercise63.2210,000632,20010,140Jun 10 04:49 PM
Olian Judy D.DirectorJun 08Sale124.964,510563,5913,490Jun 08 06:38 PM
ROTHBLATT MARTINE AChairman & CEOJun 08Sale124.7510,0001,247,525140Jun 10 04:49 PM
ROTHBLATT MARTINE AChairman & CEOJun 05Option Exercise63.2210,000632,20010,140Jun 05 06:53 PM
ROTHBLATT MARTINE AChairman & CEOJun 05Sale123.5910,0001,235,862140Jun 05 06:53 PM
ROTHBLATT MARTINE AChairman & CEOJun 04Option Exercise63.2210,000632,20010,140Jun 05 06:53 PM
CAUSEY CHRISTOPHERDirectorJun 04Option Exercise63.9075047,9251,575Jun 05 06:18 PM
ROTHBLATT MARTINE AChairman & CEOJun 04Sale123.5510,0001,235,493140Jun 05 06:53 PM
ROTHBLATT MARTINE AChairman & CEOJun 03Option Exercise63.2210,000632,20010,140Jun 03 06:28 PM
ROTHBLATT MARTINE AChairman & CEOJun 03Sale124.5210,0001,245,215140Jun 03 06:28 PM
ROTHBLATT MARTINE AChairman & CEOJun 02Option Exercise63.2210,000632,20010,140Jun 03 06:28 PM